|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5000 CAD | 0.00% |
|
-1.96% | +9.89% |
| 06-03 | PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James | MT |
| 06-01 | Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.97x | 20.32x | 43.14x | - | 62.49M | ||
| 18.08x | 1.58x | 2.66x | 0.76x | 11.93x | 12.81x | -.--% | 15.56B | ||
| 21.53x | 2.62x | 0.38x | 1.07x | 16.55x | 16.92x | -.--% | 7.18B | ||
| 16.76x | 1.75x | 2.61x | 0.73x | 7.61x | 9.57x | 2.03% | 5.85B | ||
| 13.33x | 2.01x | 0.81x | 0.85x | 6.14x | 8.04x | 3.22% | 3.78B | ||
| 16.19x | 7.33x | 2.45x | 0.99x | 7.36x | 10.23x | 3.99% | 3.33B | ||
| 14.77x | 4.43x | 14.06x | 1.25x | 7.59x | 14.72x | 5.6% | 3.3B | ||
| 12.62x | 2.36x | 0.61x | 0.51x | 4.05x | 6.68x | 5.36% | 2.77B | ||
| 40.95x | - | 1.3x | - | - | - | - | 2.66B | ||
| 23.41x | 3.96x | 1.05x | 0.67x | 8.62x | 14.08x | 1.75% | 1.7B | ||
| -48.62x | 2.14x | 1.04x | 0.36x | 14.37x | 203.82x | 0.08% | 1.12B | ||
| 48.26x | 5.3x | 1.14x | 1.41x | 16.29x | 31.21x | - | 1.08B | ||
| 11.75x | 2.36x | -4.19x | 0.86x | 7.05x | 13.3x | 5.64% | 980M | ||
| 11.81x | 0.84x | 0.11x | 0.28x | 2.7x | 5.56x | 4.3% | 935M | ||
| 27.08x | 7.31x | 1.05x | 0.98x | 13.36x | 21.13x | 1.33% | 823M | ||
| 13.18x | 1.84x | 1.09x | 0.64x | 7.9x | 12.81x | 0.39% | 653M | ||
| Average | 16.07x | 3.27x | 1.74x | 0.89x | 10.12x | 28.27x | 2.59% | 3.24B | |
| Weighted average by Cap. | 17.82x | 2.69x | 2.40x | 0.84x | 10.34x | 17.12x | 1.76% |
- Stock Market
- Stocks
- PCRX Stock
- Sector PharmaCorp Rx Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















